GPT Healthcare Ltd

Despite a broadly positive market environment, GPT Healthcare Ltd has succumbed to a three-day losing streak, culminating in a fresh all-time low of Rs.117.9 on 23 Mar 2026. The stock’s decline contrasts sharply with the sector’s 3.36% fall and the Sensex’s 2.39% drop on the same day, underscoring a pronounced stock-specific weakness.

GPT Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

GPT Healthcare Ltd’s shares declined sharply to a new 52-week low of Rs.118.2 on 9 Mar 2026, marking a significant downturn amid broader market weakness and company-specific headwinds. The stock underperformed its sector and key indices, reflecting ongoing concerns about its financial performance and investor sentiment.

GPT Healthcare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 September 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 09 March 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.

GPT Healthcare Ltd’s shares declined to a fresh all-time low of Rs.118.2 on 9 Mar 2026, marking a significant milestone in the stock’s extended downward trajectory. The hospital sector stock has underperformed both its sector peers and the broader market indices over multiple time frames, reflecting persistent pressures on its financial performance and investor sentiment.

GPT Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 September 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 09 March 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and overall outlook.

GPT Healthcare Ltd’s shares declined to a fresh 52-week low of Rs.119.8 today, marking a significant milestone in the stock’s ongoing downward trajectory. The stock has underperformed its sector and broader market indices, reflecting a series of financial setbacks and subdued investor sentiment.

Shares of GPT Healthcare Ltd have declined to an all-time low, reflecting sustained underperformance across multiple time frames and financial metrics. The hospital sector stock has witnessed a steady erosion in value, now trading just 0.41% above its 52-week low of ₹120.25, signalling a challenging period for the company and its shareholders.

GPT Healthcare Ltd’s shares declined to a fresh 52-week low of Rs.120.25 on 4 March 2026, marking a significant milestone in the stock’s ongoing downward trajectory. This new low reflects a continuation of recent price weakness amid broader sectoral and company-specific pressures.

GPT Healthcare Ltd’s shares declined to a fresh 52-week low of Rs.120.75 on 2 Mar 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The hospital sector stock has underperformed both its sector peers and the broader market, reflecting a combination of subdued financial results and waning institutional interest.

Shares of GPT Healthcare Ltd, a player in the hospital sector, have declined to an all-time low of Rs.121, marking a significant milestone in the stock’s extended downward trajectory. The stock’s recent performance reflects persistent pressures amid subdued financial results and waning institutional interest.

GPT Healthcare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 September 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 25 February 2026, providing investors with the latest insights into the stock’s performance and outlook.

GPT Healthcare Ltd’s shares declined to a fresh 52-week low of Rs.123.05 on 24 Feb 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The hospital sector stock has underperformed both its sector peers and the broader market, reflecting a series of financial setbacks and subdued investor participation.

GPT Healthcare Ltd’s stock plummeted to a new all-time low of ₹123.05 on 24 Feb 2026, marking a significant milestone in its ongoing decline. The hospital sector stock has underperformed both its sector peers and the broader market, reflecting sustained pressures on its financial performance and investor sentiment.

GPT Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 September 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 14 February 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.